Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia
Androgenetic Alopecia
About this trial
This is an interventional treatment trial for Androgenetic Alopecia focused on measuring Finasteride topical, Minoxidil topical, Male androgenetic alopecia
Eligibility Criteria
Inclusion Criteria: Male aged from 18-59 years diagnosed with androgenic alopecia Androgenic alopecia type III-V according to Hamilton-Norwood criteria Willing to participate in this research by signing the consent form after receiving an explanation from the researcher Willing to not cutting the hair nor coloring the hair during the study Exclusion Criteria: Diagnosed with other infectious or inflammatory skin disease in the scalp Using oral medications or vitamins that aim to increase the amount of hair in the last 1 month Using topical medication that aim to increase the amount of hair in the last 2 weeks Undergoing cosmetic procedure for AGA therapy such as low-level laser therapy (LLLT) procedures, platelet-rich plasma (PRP) injections, or microneedling within the last 3 months Have sexual disorder such as decreased libido Have a history of allergy or irritant contact dermatitis to the minoxidil and finasteride
Sites / Locations
- University IndonesiaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Combination of minoxidil 5% topical and finasteride 0,1% topical group
Minoxidil 5% topical group
Combination of minoxidil 5% solutio and finasteride 0,1% solutio which has administered topically
Minoxidil 5% solutio which has administered topically